These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28404737)

  • 21. Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System.
    Proenca-Modena JL; Hyde JL; Sesti-Costa R; Lucas T; Pinto AK; Richner JM; Gorman MJ; Lazear HM; Diamond MS
    J Virol; 2016 Jan; 90(1):189-205. PubMed ID: 26468541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
    Honda K; Taniguchi T
    Nat Rev Immunol; 2006 Sep; 6(9):644-58. PubMed ID: 16932750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis of organizational and expressional characterizations of the IFNs, IRFs and CRFBs in grass carp Ctenopharyngodon idella.
    Liao Z; Wan Q; Su J
    Dev Comp Immunol; 2016 Aug; 61():97-106. PubMed ID: 27012995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?
    Thompson CD; Matta B; Barnes BJ
    Front Immunol; 2018; 9():2622. PubMed ID: 30515152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IRF family of transcription factors as regulators of host defense.
    Taniguchi T; Ogasawara K; Takaoka A; Tanaka N
    Annu Rev Immunol; 2001; 19():623-55. PubMed ID: 11244049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
    Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
    Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune mechanisms in angiotensin II-induced target-organ damage.
    Luft FC; Dechend R; Müller DN
    Ann Med; 2012 Jun; 44 Suppl 1():S49-54. PubMed ID: 22713149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Amphioxus IFN Regulatory Factor Family Reveals an Archaic Signaling Framework for Innate Immune Response.
    Yuan S; Zheng T; Li P; Yang R; Ruan J; Huang S; Wu Z; Xu A
    J Immunol; 2015 Dec; 195(12):5657-66. PubMed ID: 26573836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning and characterization of interferon regulatory factor 1 (IRF-1), IRF-2 and IRF-5 in the chondrostean paddlefish Polyodon spathula and their phylogenetic importance in the Osteichthyes.
    Xiaoni G; Zhuo C; Xuzhen W; Dengqiang W; Xinwen C
    Dev Comp Immunol; 2012 Jan; 36(1):74-84. PubMed ID: 21703300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
    Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
    Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Immunological Links Between Psoriasis and Cardiovascular Disease.
    Sajja AP; Joshi AA; Teague HL; Dey AK; Mehta NN
    Front Immunol; 2018; 9():1234. PubMed ID: 29910818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunomodulating role of exercise in metabolic disease.
    Lancaster GI; Febbraio MA
    Trends Immunol; 2014 Jun; 35(6):262-9. PubMed ID: 24680647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells in cardiovascular diseases.
    Meng X; Yang J; Dong M; Zhang K; Tu E; Gao Q; Chen W; Zhang C; Zhang Y
    Nat Rev Cardiol; 2016 Mar; 13(3):167-79. PubMed ID: 26525543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.
    Szelag M; Piaszyk-Borychowska A; Plens-Galaska M; Wesoly J; Bluyssen HA
    Oncotarget; 2016 Jul; 7(30):48788-48812. PubMed ID: 27166190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiorgan, Multimodality Imaging in Cardiometabolic Disease.
    Kumar V; Hsueh WA; Raman SV
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29122843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IRF family transcription factors in immunity and oncogenesis.
    Tamura T; Yanai H; Savitsky D; Taniguchi T
    Annu Rev Immunol; 2008; 26():535-84. PubMed ID: 18303999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate and intrinsic antiviral immunity in skin.
    Kawamura T; Ogawa Y; Aoki R; Shimada S
    J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative regulation of Toll-like-receptor signaling by IRF-4.
    Negishi H; Ohba Y; Yanai H; Takaoka A; Honma K; Yui K; Matsuyama T; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15989-94. PubMed ID: 16236719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of estrogen receptor alpha and estrogen receptor beta for adipose tissue functions and cardiometabolic complications.
    Gao H; Dahlman-Wright K
    Horm Mol Biol Clin Investig; 2013 Sep; 15(3):81-90. PubMed ID: 25436735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.